Study motor function tests in FSHD
Part of Bones, joints & muscles, Genetic & congenital clinical trials.
This trial studies how well certain physical/movement tests work in people with facioscapulohumeral muscular dystrophy (FSHD). It may help clinicians measure changes more accurately and tailor care over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have FSHD confirmed by genetic testing (type 1 or 2) OR your doctor diagnosed FSHD based on exam findings and family history.
- Your diagnosis includes either an affected parent or an affected child (offspring).
- You are willing and able to sign informed consent (agree to join and understand the study).
- No other medical problem should get in the way of you participating safely or completing study tasks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine called Del-brax (AOC 1020) for people with facioscapulohumeral muscular dystrophy (FSHD). The goal is to see if it can help improve muscle strength and slow the disease. You may be able to join if you have a confirmed FSHD diagnosis and can walk at least 10 meters on your own.
This study creates a patient-driven health and research platform for people with FSHD. It aims to collect information to better understand the condition and improve future research and care.
This study tests whether a drug called apitegromab can help improve muscle function in people with facioscapulohumeral muscular dystrophy (FSHD). It is for adults aged 18-60 who have mild to moderate symptoms and can walk or run 10 meters in 5 seconds or less.
This trial tests a personalized home exercise program designed to reduce pain and fatigue in people with FSHD type 1. You would use a smartphone app to follow exercises tailored to your abilities.
This study looks at how children with FSHD move and function over time. It uses walking tests and optional MRI scans to understand muscle changes. Your child's participation could help researchers learn more about FSHD progression in kids.
This study looks at how walking changes over time in people with facioscapulohumeral muscular dystrophy (FSHD). It aims to understand walking patterns to help improve future care.
Hear when a new FSHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.